Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2406170 | Vaccine | 2010 | 11 Pages |
Abstract
A distinguishing feature of HCV is its ability to persist in majority of the infected people. We investigated the role of HCV-core and NS3 in inducing effector T cells to mediate antiviral immunity. Our studies revealed that immunization with recombinant adenoviral vector containing HCV-core or NS3 leads to differential development of regulatory vs. effector T cells in mice, resulting in distinct outcomes of virus infection. For the first time, our studies directly demonstrate that HCV-core enhances both CD4+ and CD8+ Tregs which possibly contribute to persistent infection, whereas HCV NS3 induces both CD4+ and CD8+ effector T cells to allow viral clearance.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Deepa K. Krishnadas, Wen Li, Rakesh Kumar, D. Lorne Tyrrell, Babita Agrawal,